Literature DB >> 27569280

Respiratory syncytial virus non-structural protein 1 facilitates virus replication through miR-29a-mediated inhibition of interferon-α receptor.

Yao Zhang1, Lihua Yang1, Hao Wang1, Guocheng Zhang2, Xin Sun3.   

Abstract

Human respiratory syncytial virus (RSV) non-structural protein 1 (NS1) has recently been suggested to inhibit type-I interferon (IFN)-dependent immune responses during RSV infection. However, the precise function of RSV NS1 protein in reducing the antiviral effects of IFNs against RSV is poorly understood. The roles of cellular miRNAs in the defence against RSV infection are not well characterized. In this study, qRT-PCR analysis revealed that miR-29a expression was upregulated in the recombinant wild-type RSV (rRSV-WT) group compared with the control group, but no changes were observed in the recombinant RSV mutant lacking NS1 (rRSVNS1) group. Using dual-luciferase reporter assay, we demonstrated that miR-29a could directly target IFNAR1 3'-UTR and downregulate IFNAR1 expression. In addition, RSV NS1 suppressed IFNAR1 expression at both RNA level and protein level in human lung adenocarcinoma cell line A549. RSV plaque assays showed that the number of RSV plaques in miR-29a mimics group was significantly higher than that in miR-29a inhibitor group or miRNA scramble control group. HA-NS1 overexpression increased the numbers of RSV plaque, but the promotive effect on virus replication was attenuated in cells transfected with miR-29a inhibitors. These results suggest that miR-29a, upregulated during RSV infection, is a negative regulator of IFNAR1 and is critical for RSV NS1-induced virus replication.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Interferon-α receptor; Non-structural protein 1; Replication; Respiratory syncytial virus; miR-29a

Mesh:

Substances:

Year:  2016        PMID: 27569280     DOI: 10.1016/j.bbrc.2016.08.142

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Structural basis for IFN antagonism by human respiratory syncytial virus nonstructural protein 2.

Authors:  Jingjing Pei; Nicole D Wagner; Angela J Zou; Srirupa Chatterjee; Dominika Borek; Aidan R Cole; Preston J Kim; Christopher F Basler; Zbyszek Otwinowski; Michael L Gross; Gaya K Amarasinghe; Daisy W Leung
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-09       Impact factor: 11.205

2.  Interferon down-regulation of miR-1225-3p as an antiviral mechanism through modulating Grb2-associated binding protein 3 expression.

Authors:  Min Cheng; Yuqiang Niu; Jingjing Fan; Xiaojing Chi; Xiuying Liu; Wei Yang
Journal:  J Biol Chem       Date:  2018-03-01       Impact factor: 5.157

Review 3.  The Dynamic Interface of Viruses with STATs.

Authors:  Angela R Harrison; Gregory W Moseley
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

Review 4.  Interplay between Janus Kinase/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism.

Authors:  Yuchen Nan; Chunyan Wu; Yan-Jin Zhang
Journal:  Front Immunol       Date:  2017-12-11       Impact factor: 7.561

Review 5.  Viruses and miRNAs: More Friends than Foes.

Authors:  Patrice Bruscella; Silvia Bottini; Camille Baudesson; Jean-Michel Pawlotsky; Cyrille Feray; Michele Trabucchi
Journal:  Front Microbiol       Date:  2017-05-15       Impact factor: 5.640

6.  Comparative analysis of miRNA profile in human dendritic cells infected with respiratory syncytial virus and human metapneumovirus.

Authors:  Ma Del Rocio Baños-Lara; Jovanny Zabaleta; Jone Garai; Melody Baddoo; Antonieta Guerrero-Plata
Journal:  BMC Res Notes       Date:  2018-07-03

7.  Human Respiratory Syncytial Virus NS 1 Targets TRIM25 to Suppress RIG-I Ubiquitination and Subsequent RIG-I-Mediated Antiviral Signaling.

Authors:  Junsu Ban; Na-Rae Lee; Noh-Jin Lee; Jong Kil Lee; Fu-Shi Quan; Kyung-Soo Inn
Journal:  Viruses       Date:  2018-12-14       Impact factor: 5.048

Review 8.  Cytokines in the Respiratory Airway as Biomarkers of Severity and Prognosis for Respiratory Syncytial Virus Infection: An Update.

Authors:  Yaneisi Vázquez; Liliana González; Loreani Noguera; Pablo A González; Claudia A Riedel; Pablo Bertrand; Susan M Bueno
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 7.561

9.  Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response.

Authors:  Krist Helen Antunes; José Luís Fachi; Rosemeire de Paula; Emanuelle Fraga da Silva; Laís Passariello Pral; Adara Áurea Dos Santos; Greicy Brisa Malaquias Dias; José Eduardo Vargas; Renato Puga; Fabiana Quoos Mayer; Fábio Maito; Carlos R Zárate-Bladés; Nadim J Ajami; Marcella Ramos Sant'Ana; Thamiris Candreva; Hosana Gomes Rodrigues; Marcio Schmiele; Maria Teresa Pedrosa Silva Clerici; José Luiz Proença-Modena; Angélica Thomas Vieira; Charles R Mackay; Daniel Mansur; Mauricio T Caballero; Jacqui Marzec; Jianying Li; Xuting Wang; Douglas Bell; Fernando P Polack; Steven R Kleeberger; Renato T Stein; Marco Aurélio Ramirez Vinolo; Ana Paula Duarte de Souza
Journal:  Nat Commun       Date:  2019-07-22       Impact factor: 14.919

Review 10.  Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity.

Authors:  Gisela Canedo-Marroquín; Orlando Acevedo-Acevedo; Emma Rey-Jurado; Juan M Saavedra; Margarita K Lay; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Front Cell Infect Microbiol       Date:  2017-08-16       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.